19.01.2013
- Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...
18.01.2013
- Roche Holding said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules, and that the extra supplies of the flu treatment should...
16.01.2013
- Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...
15.01.2013
- AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations. Pascal Soriot, who took...
15.01.2013
- The Bio-Process Systems Alliance (BPSA) is pleased to announce it has elected five Executive Board members who will serve in leadership positions through December 31, 2015, to...
09.01.2013
- BioMarin Pharmaceutical, which makes high-priced drugs used to treat rare diseases, would not consider a buy-out offer for even a 25-30% premium, according to the company's chief...
08.01.2013
- Hookipa Biotech, a vaccine biotech start up pioneering a new class of vaccines, today announced the appointment of two new members to its management team: Thomas P. Monath as Chief...
07.01.2013
- Sanofi is pleased to announce today the appointment of Dr. Gary J. Nabel, M.D., Ph.D., to Chairman of the Strategic Development and Scientific Advisory Council (SDSAC). Dr. Nabel...
03.01.2013
- Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
